Stock data
BeOne Medicines Ltd. (ONC)
BeOne Medicines Ltd. (ONC) reported revenue of US$5.34B and net income of US$286.93M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$5.34B | US$4.67B | US$447.14M | US$286.93M | — |
| 2024 | US$3.81B | US$3.22B | -US$568.20M | -US$644.79M | — |
| 2023 | US$2.46B | US$2.08B | -US$1.21B | -US$881.71M | — |
| 2022 | US$1.42B | US$1.13B | -US$1.79B | -US$2.00B | — |
| 2021 | US$1.18B | US$1.01B | -US$1.44B | -US$1.46B | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$1.71B | US$237.01M | — |
| 2026-03-31 | US$1.51B | US$227.36M | — |
| 2025-12-31 | US$1.50B | US$66.50M | — |
| 2025-09-30 | US$1.41B | US$124.84M | — |
| 2025-06-30 | US$1.32B | US$94.32M | — |
| 2025-03-31 | US$1.12B | US$1.27M | — |
| 2024-12-31 | US$1.13B | -US$151.88M | — |
| 2024-09-30 | US$1.00B | -US$121.35M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.